Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target.

Manni ME, Rigacci S, Borchi E, Bargelli V, Miceli C, Giordano C, Raimondi L, Nediani C.

Oxid Med Cell Longev. 2016;2016:4375418. doi: 10.1155/2016/4375418. Epub 2016 Dec 1.

2.

Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes.

Sartiani L, Bucciantini M, Spinelli V, Leri M, Natalello A, Nosi D, Maria Doglia S, Relini A, Penco A, Giorgetti S, Gerace E, Mannaioni G, Bellotti V, Rigacci S, Cerbai E, Stefani M.

Biophys J. 2016 Nov 1;111(9):2024-2038. doi: 10.1016/j.bpj.2016.09.010.

3.

Nutraceutical Properties of Olive Oil Polyphenols. An Itinerary from Cultured Cells through Animal Models to Humans.

Rigacci S, Stefani M.

Int J Mol Sci. 2016 May 31;17(6). pii: E843. doi: 10.3390/ijms17060843. Review.

4.

Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight.

Rigacci S, Miceli C, Nediani C, Berti A, Cascella R, Pantano D, Nardiello P, Luccarini I, Casamenti F, Stefani M.

Oncotarget. 2015 Nov 3;6(34):35344-57. doi: 10.18632/oncotarget.6119.

5.

Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer's Disease.

Rigacci S.

Adv Exp Med Biol. 2015;863:1-20. doi: 10.1007/978-3-319-18365-7_1. Review.

PMID:
26092624
6.

Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease.

Casamenti F, Grossi C, Rigacci S, Pantano D, Luccarini I, Stefani M.

J Alzheimers Dis. 2015;45(3):679-88. doi: 10.3233/JAD-142850. Review.

PMID:
25649656
7.

Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols.

Rigacci S, Stefani M.

Expert Rev Neurother. 2015 Jan;15(1):41-52. doi: 10.1586/14737175.2015.986101. Epub 2014 Nov 24. Review.

PMID:
25418871
8.

Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates.

Luccarini I, Grossi C, Rigacci S, Coppi E, Pugliese AM, Pantano D, la Marca G, Ed Dami T, Berti A, Stefani M, Casamenti F.

Neurobiol Aging. 2015 Feb;36(2):648-63. doi: 10.1016/j.neurobiolaging.2014.08.029. Epub 2014 Sep 6.

PMID:
25293421
9.

Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation.

Stefani M, Rigacci S.

Biofactors. 2014 Sep-Oct;40(5):482-93. doi: 10.1002/biof.1171. Epub 2014 Jun 3. Review.

PMID:
24890399
10.

Amyloid Aggregation: Role of Biological Membranes and the Aggregate-Membrane System.

Bucciantini M, Rigacci S, Stefani M.

J Phys Chem Lett. 2014 Feb 6;5(3):517-27. doi: 10.1021/jz4024354. Epub 2014 Jan 24.

PMID:
26276603
11.

Mild exposure of RIN-5F β-cells to human islet amyloid polypeptide aggregates upregulates antioxidant enzymes via NADPH oxidase-RAGE: an hormetic stimulus.

Borchi E, Bargelli V, Guidotti V, Berti A, Stefani M, Nediani C, Rigacci S.

Redox Biol. 2013 Dec 17;2:114-22. doi: 10.1016/j.redox.2013.12.005. eCollection 2013.

12.

Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain.

Luccarini I, Ed Dami T, Grossi C, Rigacci S, Stefani M, Casamenti F.

Neurosci Lett. 2014 Jan 13;558:67-72. doi: 10.1016/j.neulet.2013.10.062. Epub 2013 Nov 7.

PMID:
24211687
13.

Employing Alzheimer disease animal models for translational research: focus on dietary components.

Grossi C, Ed Dami T, Rigacci S, Stefani M, Luccarini I, Casamenti F.

Neurodegener Dis. 2014;13(2-3):131-4. doi: 10.1159/000355461. Epub 2013 Oct 30.

PMID:
24192327
14.

The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology.

Grossi C, Rigacci S, Ambrosini S, Ed Dami T, Luccarini I, Traini C, Failli P, Berti A, Casamenti F, Stefani M.

PLoS One. 2013 Aug 8;8(8):e71702. doi: 10.1371/journal.pone.0071702. eCollection 2013.

15.

Protein folding and aggregation into amyloid: the interference by natural phenolic compounds.

Stefani M, Rigacci S.

Int J Mol Sci. 2013 Jun 13;14(6):12411-57. doi: 10.3390/ijms140612411. Review.

16.

Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ42 by reducing plaque load and motor deficit.

Diomede L, Rigacci S, Romeo M, Stefani M, Salmona M.

PLoS One. 2013;8(3):e58893. doi: 10.1371/journal.pone.0058893. Epub 2013 Mar 8.

17.

Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon.

Rigacci S, Guidotti V, Bucciantini M, Nichino D, Relini A, Berti A, Stefani M.

Curr Alzheimer Res. 2011 Dec;8(8):841-52.

PMID:
21592051
18.

Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin.

Rigacci S, Guidotti V, Bucciantini M, Parri M, Nediani C, Cerbai E, Stefani M, Berti A.

J Nutr Biochem. 2010 Aug;21(8):726-35. doi: 10.1016/j.jnutbio.2009.04.010. Epub 2009 Jul 18.

PMID:
19616928
19.

The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies.

Rigacci S, Bucciantini M, Relini A, Pesce A, Gliozzi A, Berti A, Stefani M.

Biophys J. 2008 May 1;94(9):3635-46. doi: 10.1529/biophysj.107.122283. Epub 2008 Jan 16.

20.

Modulation of STAT5 interaction with LMW-PTP during early megakaryocyte differentiation.

Rigacci S, Guidotti V, Parri M, Berti A.

Biochemistry. 2008 Feb 12;47(6):1482-9. doi: 10.1021/bi701131e. Epub 2008 Jan 16.

PMID:
18197699

Supplemental Content

Loading ...
Support Center